Phase I/II study of single-agent bortezomib for the treatment of patients with myelofibrosis. Clinical and biological effects of proteasome inhibition

Title
Phase I/II study of single-agent bortezomib for the treatment of patients with myelofibrosis. Clinical and biological effects of proteasome inhibition
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF HEMATOLOGY
Volume 85, Issue 8, Pages 616-619
Publisher
Wiley
Online
2010-05-06
DOI
10.1002/ajh.21754

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started